Ludwigshafen, Germany - October 13, 2017 - BASF has signed an agreement to acquire significant parts of Bayer's seed and non-selective herbicide businesses. Bayer intends to divest these assets in the context of its planned acquisition of Monsanto. The all-cash purchase price is EUR5.9 billion, subject to certain adjustments at closing. For the full year 2016, sales of the business to be purchased from Bayer amounted to around EUR1.3 billion and EBITDA to around EUR385 million. The transaction is subject to the closing of Bayer's acquisition of Monsanto and approval by relevant authorities. It is expected to close in the first quarter of 2018.
|
The approximately 114,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world.
Photo courtesy of BASF |
|
Ludwigshafen, Germany – October 13, 2017
• Strengthens and expands BASF’s Agricultural Solutions offer
• Attractive and targeted portfolio additions in key row crops in select countries
• Underpins BASF’s commitment to agriculture, innovation and long-term growth
BASF has signed an agreement to acquire significant parts of Bayer’s seed and non-selective herbicide businesses.
Bayer intends to divest these assets in the context of its planned acquisition of Monsanto.
|
Photo courtesy of BASF |
|
The all-cash purchase price is EUR 5.9 billion, subject to certain adjustments at closing.
|
The acquisition includes seed assets for key row crops (cotton, canola, soy) and will be a strategic complement to BASF’s well-established and successful crop protection business.
Photo courtesy of BASF |
|
The assets to be acquired include Bayer’s global glufosinate-ammonium non-selective herbicide business, commercialized under the Liberty®, Basta® and Finale® brands, as well as its seed businesses for key row crops in select markets: canola hybrids in North America under the InVigor® brand using the LibertyLink® trait technology, oilseed rape mainly in European markets, cotton in the Americas and Europe as well as soybean in the Americas.
|
The assets to be acquired by BASF include an attractive seed portfolio for canola / oilseed rape, mainly in North America and Europe.
Photo courtesy of BASF |
|
The transaction also includes Bayer’s trait research and breeding capabilities for these crops and the LibertyLink® trait and trademark.
For the full year 2016, sales of the business to be purchased from Bayer amounted to around EUR 1.3 billion and EBITDA to around EUR 385 million.
|
With an enhanced portfolio, BASF will offer farmers a greater choice of solutions, including high quality soy, canola and cotton seeds.
Photo courtesy of BASF |
|
The transaction is subject to the closing of Bayer’s acquisition of Monsanto and approval by relevant authorities.
It is expected to close in the first quarter of 2018.
|
Photo courtesy of BASF |
|
“With this investment, we are seizing the opportunity to acquire highly attractive assets in key row crops and markets. It will be a strategic complement to BASF’s well-established and successful crop protection business as well as to our own activities in biotechnology,” said Dr. Kurt Bock, Chairman of the Board of Executive Directors of BASF SE.
“The acquisition will further enhance our agricultural solutions offer, which is a core pillar of BASF’s portfolio.”
|
Photo courtesy of BASF |
|
The acquisition complements BASF’s crop protection business, strengthening the company’s herbicide portfolio and marking its entry into the seed business with proprietary assets in key agricultural markets.
|
Photo courtesy of BASF |
|
“Building on the competent new team members and the enhanced portfolio, we will offer farmers a greater choice of solutions addressing their needs for high-quality seeds, chemical and biological crop protection,” explained Saori Dubourg, Member of the Board of Executive Directors of BASF SE and responsible for the Agricultural Solutions segment.
“Moreover, this transaction will create new opportunities for future growth and strengthen our global innovation potential.”
|
Photo courtesy of BASF |
|
More than 1,800 commercial, R&D, breeding and production personnel shall transfer from Bayer to BASF.
These employees are primarily located in the United States, Germany, Brazil, Canada and Belgium.
|
Photo courtesy of BASF |
|
Furthermore, BASF will acquire the manufacturing sites for glufosinate-ammonium production and formulation in Germany, the United States, and Canada, seed breeding facilities in the Americas and Europe as well as trait research facilities in the United States and Europe.
|
Photo courtesy of BASF |
|
“We look forward to welcoming our new colleagues to BASF. As highly experienced, dedicated and motivated professionals they will enrich our team with their expert knowledge in crop protection, seeds and traits. Together, we will shape the long-term success of BASF, serving the needs of farmers around the globe,” said Markus Heldt, President of BASF’s Crop Protection division.
|
Photo courtesy of BASF |
|
For further information, please go to
https://www.basf.com/en/microsites/grow-with-us.html
About BASF
At BASF, we create chemistry for a sustainable future.
We combine economic success with environmental protection and social responsibility.
The approximately 114,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world.
Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas.
BASF generated sales of about EUR 58 billion in 2016.
BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (BAS).
Further information at www.basf.com
About BASF’s Crop Protection division
With a rapidly growing population, the world is increasingly dependent on our ability to develop and maintain sustainable agriculture and healthy environments.
BASF’s Crop Protection division works with farmers, agricultural professionals, pest management experts and others to help make this possible.
|
Photo courtesy of BASF |
|
With their cooperation, BASF is able to sustain an active R&D pipeline, an innovative portfolio of products and services, and teams of experts in the lab and in the field to support customers in making their businesses succeed.
In 2016, BASF’s Crop Protection division generated sales of EUR 5.6 billion.
For more information, please visit us at
https://agriculture.basf.com/en.html
or on any of our social media channels.
Contact:
Business Media
Jens Fey
Media Relations
Phone: +49 621 60-99123
jens.fey@basf.com
Trade Media
Dr. Kristina Winzen
Phone: +49 621 60-28633
kristina.winzen@basf.com
Investor Relations
Dr. Stefanie Wettberg
Phone: +49 621 60-48002
stefanie.wettberg@basf.com
BASF SE
67056 Ludwigshafen
Phone: +49 621 60-0
http://www.basf.com/
Media Relations
Phone: +49 621 60-20916
presse.kontakt@basf.com
Source: BASF SE
https://www.basf.com/de/en.html
ASTROMAN Magazine - 2017.10.12
BASF: High gloss in automotive interiors
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=2359
ASTROMAN Magazine - 2017.10.01
Crop Science Division of Bayer well positioned to fulfill future customer, market and societal needs. Progress being made in planned Monsanto acquisition
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=2349
ASTROMAN Magazine - 2017.09.26
Selena Group becomes a member of the European Cool Roof Council
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=2343
ASTROMAN Magazine - 2017.09.03
DowDuPont Merger Successfully Completed. Global Leaders in Agriculture, Materials Science and Specialty Products
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=2327
ASTROMAN Magazine - 2017.08.06
DuPont and Dow Set Closing Date for Merger of Equals
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=2307
ASTROMAN Magazine - 2017.07.01
Dr. Bertalan Mesko, PhD: The Top 10 Trends Shaping the Future of Pharma
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=2286
Editor-in-Chief of ASTROMAN magazine: Roman Wojtala, Ph.D.
|